Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Internal Medicine (Tokyo, Japan)|July 30, 2025
A Case of Adult T-Cell Leukemia Following Satralizumab Treatment for Neuromyelitis Optica Spectrum DisorderKenzo Sakurai, Yumi Ashikawa, Yoichiro Imaoka, et al.
Cancer Science|March 12, 2014
High-resolution genomic copy number profiling of primary intraocular lymphoma by single nucleotide polymorphism microarraysLudan Wang, Aiko Sato-Otsubo, Sunao Sugita, et al.
American Journal of Hematology|February 6, 2009
Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study GroupMakoto Hirokawa, Ken-ichi Sawada, Naohito Fujishima, et al.
The Journal of Infectious Diseases|March 31, 2026
Long-term outcomes of chronic active Epstein-Barr virus infection in childhood after dominantly infected lymphocyte subpopulation managementNobutaka Harada, Motoshi Sonoda, Sungyeon Park, et al.
Clinical Journal of Gastroenterology|April 11, 2019
Indolent T cell lymphoproliferative disorder with villous atrophy in small intestine diagnosed by single-balloon enteroscopyTakashi Nagaishi, Daiki Yamada, Kohei Suzuki, et al.
British Journal of Haematology|December 22, 2023
Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphomaYotaro Motomura, Kota Yoshifuji, Takayoshi Tachibana, et al.
Blood Neoplasia|June 23, 2025
JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 studyYu Uemura, Masahide Yamamoto, Masataka Ishimura, et al.
Plos One|November 20, 2014
CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signalsMayumi Yoshimori, Ken-Ichi Imadome, Honami Komatsu, et al.
International Journal of Hematology|September 20, 2023
Updated guidelines for chronic active Epstein-Barr virus diseaseJun-Ichi Kawada, Yoshinori Ito, Koichi Ohshima, et al.
Plos One|August 2, 2017
Correction: EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cellsHonami Takada, Ken-Ichi Imadome, Haruna Shibayama, et al.
Pageof 11